Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
Contenuto fornito da The PJ Pod and Pharmaceutical Journal. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The PJ Pod and Pharmaceutical Journal o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !
Vai offline con l'app Player FM !
Can antiviral drugs turn the tide on COVID-19?
Manage episode 323237385 series 3329558
Contenuto fornito da The PJ Pod and Pharmaceutical Journal. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The PJ Pod and Pharmaceutical Journal o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
There have been claims that COVID-19 oral antivirals, such as molnupiravir and Paxlovid (nirmatrelvir + ritonavir), will “change the course of the pandemic”. But with limited supply, a short treatment window and only a few patient groups eligible to receive them — can these drugs really turn things around? In this episode, Dawn Connelly, features editor, and Julia Robinson, clinical and science editor, answer questions from PJ readers on how they will be used in practice. They are joined by Penny Ward, visiting professor in pharmaceutical medicine at King’s College London, and Fiona Marra, a consultant infectious disease pharmacist based in Scotland. Thank you to Rob Ardley, Nicola Vasey, Umeh Ali and Gareth Malson for their questions. This episode was produced by Geoff Marsh.
…
continue reading
46 episodi
Manage episode 323237385 series 3329558
Contenuto fornito da The PJ Pod and Pharmaceutical Journal. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da The PJ Pod and Pharmaceutical Journal o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
There have been claims that COVID-19 oral antivirals, such as molnupiravir and Paxlovid (nirmatrelvir + ritonavir), will “change the course of the pandemic”. But with limited supply, a short treatment window and only a few patient groups eligible to receive them — can these drugs really turn things around? In this episode, Dawn Connelly, features editor, and Julia Robinson, clinical and science editor, answer questions from PJ readers on how they will be used in practice. They are joined by Penny Ward, visiting professor in pharmaceutical medicine at King’s College London, and Fiona Marra, a consultant infectious disease pharmacist based in Scotland. Thank you to Rob Ardley, Nicola Vasey, Umeh Ali and Gareth Malson for their questions. This episode was produced by Geoff Marsh.
…
continue reading
46 episodi
Todos os episódios
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.